Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Michael Burry who wrote (627)	12/20/1997 12:16:00 AM
From: jeffbas	Read Replies (1) \| Respond to of 2068

I am not familiar with the specifics of the Freedom Plan and would be able to comment better if I were, having done these kinds of evaluations personally. However, a plan with low copays, rich benefits and complete freedom of choice is merely a souped-up indemnity plan dressed up in HMO sheep's clothing. It should not be too hard to analyze expected claim costs - very high. By the way, this industry is so competitive and insuring capacity so easy to produce, that it should always be a warning sign that you are doing something wrong if your sales are skyrocketing. (When the actuaries had reasonable input into the process, we always had to fight tooth and nail for every sale, in either HMO or indemnity business.)